Clinical Lymphoma Myeloma and Leukemia

1

Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Mathisen, Michael S., Kantarjian, Hagop, Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, Borthakur, Gautam, Cortes, Jorge E., Quintás-Cardama, Alfonso

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 304 KB

english, 2013

2

Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

Casulo, Carla, Maragulia, Jocelyn, Zelenetz, Andrew D.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 288 KB

english, 2013

3

Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine

Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, O'Brien, Susan, Fullmer, Amber, Cortes, Jorge E., Wierda, William, Kantarjian, Hagop

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 390 KB

english, 2013

4

Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories

Falantes, Jose F., Calderón, Cristina, Márquez Malaver, Francisco J., Alonso, Dora, Martín Noya, Antonio, Carrillo, Estrella, Martino, María L., Montero, Isabel, González, Jose, Parody, Rocío, Espigad

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 498 KB

english, 2013

5

Survival in Monoclonal Gammopathy of Undetermined Significance and Waldenström Macroglobulinemia

Kristinsson, Sigurdur Y., Björkholm, Magnus, Landgren, Ola

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 374 KB

english, 2013

6

Targeting the Toll-like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Loiarro, Maria, Ruggiero, Vito, Sette, Claudio

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 448 KB

english, 2013

7

Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia

Poulain, Stéphanie, Herbaux, Charles, Bertrand, Elisabeth, Decambron, Audrey, Fouquet, Guillemette, Boyle, Eileen, Gay, Julie, Manier, Salomon, Duthilleul, Patrick, Roumier, Christophe, Leleu, Xavier

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 473 KB

english, 2013

8

A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature

Ragupathi, Loheetha, Najfeld, Vesna, Chari, Ajai, Petersen, Bruce, Jagannath, Sundar, Mascarenhas, John

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 475 KB

english, 2013

9

Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia

Dimopoulos, Meletios A., Terpos, Evangelos, Kastritis, Efstathios

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 174 KB

english, 2013

10

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Westin, Jason R., Thompson, Michael A., Cataldo, Vince D., Fayad, Luis E., Fowler, Nathan, Fanale, Michelle A., Neelapu, Saatva, Samaniego, Felipe, Romaguera, Jorge, Shah, Jatin, McLaughlin, Peter, Pr

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 513 KB

english, 2013

11

microRNA Aberrations in Waldenström Macroglobulinemia

Sacco, Antonio, Zhang, Yong, Maiso, Patricia, Manier, Salomon, Rossi, Giuseppe, Treon, Steven P., Ghobrial, Irene M., Roccaro, Aldo M.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 454 KB

english, 2013

12

Role of Plasmapheresis in Waldenström's Macroglobulinemia

Stone, Marvin J., Bogen, Steven A.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 383 KB

english, 2013

13

Desensitization to Lenalidomide in a Patient With Relapsed Multiple Myeloma

Seki, Jack T., Banglawala, Sabiha, Lentz, Emily M., Reece, Donna E.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 199 KB

english, 2013

14

Successful Use of Intrathecal Carboxypeptidase G2 for Intrathecal Methotrexate Overdose: A Case Study and Review of the Literature

Bradley, Amber M., Buie, Larry W., Kuykendal, Adam, Voorhees, Peter M.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 252 KB

english, 2013

16

Patients With Waldenström Macroglobulinemia Commonly Present With Iron Deficiency and Those With Severely Depressed Transferrin Saturation Levels Show Response to Parenteral Iron Administration

Treon, Steven P., Tripsas, Christina K., Ciccarelli, Bryan T., Manning, Robert J., Patterson, Christopher J., Sheehy, Patricia, Hunter, Zachary R.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 175 KB

english, 2013

17

Therapy of Core Binding Factor Acute Myeloid Leukemia: Incremental Improvements Toward Better Long-Term Results

Bhatt, Vijaya Raj, Kantarjian, Hagop, Cortes, Jorge E., Ravandi, Farhad, Borthakur, Gautam

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 296 KB

english, 2013

18

Intraclonal Heterogeneity in Concomitant Monoclonal Lymphocyte and Plasma Cell Populations: Combining Flow Cytometric Cell Sorting With Molecular Monoclonality Profiling

Zehentner, Barbara K., de Baca, Monica E., Wells, Denise A., Loken, Michael R.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 888 KB

english, 2013

19

Genomic Abnormalities of Waldenström Macroglobulinemia and Related Low-Grade B-Cell Lymphomas

Braggio, Esteban, Fonseca, Rafael

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 607 KB

english, 2013

20

Bortezomib Administration With Severe Hyperbilirubinemia Caused by Hepatic Plasma Cell Infiltration: A Case Report

Wilson, Nicole, Surati, Minal, Walker, Bruce F., Kaufman, Jonathan L., Harvey, R. Donald

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 615 KB

english, 2013

21

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Agarwal, Amit, Ghobrial, Irene M.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 654 KB

english, 2013

22

Etiology of Waldenström Macroglobulinemia: Genetic Factors and Immune-related Conditions

Manasanch, Elisabet E., Kristinsson, Sigurdur Y., Landgren, Ola

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 231 KB

english, 2013

23

Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenström Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance

Trojani, Alessandra, Greco, Antonino, Tedeschi, Alessandra, Lodola, Milena, Di Camillo, Barbara, Ricci, Francesca, Turrini, Mauro, Varettoni, Marzia, Rattotti, Sara, Morra, Enrica

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 789 KB

english, 2013

24

Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia

Tedeschi, Alessandra, Ricci, Francesca, Goldaniga, Maria Cecilia, Benevolo, Giulia, Varettoni, Marzia, Motta, Marina, Pioltelli, Pietro, Gini, Guido, Barate', Claudia, Luraschi, Annamaria, Vismara, El

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 214 KB

english, 2013

25

Editorial Board/Masthead

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 75 KB

english, 2013

26

Proceedings of the Seventh International Workshop on Waldenström Macroglobulinemia

Treon, Steven P., Patterson, Christopher J., Munshi, Nikhil C., Anderson, Kenneth C.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 779 KB

english, 2013

27

Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib

Smetana, Jan, Berankova, Kristina, Zaoralova, Romana, Nemec, Pavel, Greslikova, Henrieta, Kupska, Renata, Mikulasova, Aneta, Frohlich, Jan, Sevcikova, Sabina, Zahradova, Lucie, Krejci, Marta, Sandecka

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 355 KB

english, 2013

28

Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells

de Tute, Ruth M., Rawstron, Andy C., Owen, Roger G.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 420 KB

english, 2013

29

Diagnostic Challenges of Amyloidosis in Waldenström Macroglobulinemia

Palladini, Giovanni, Merlini, Giampaolo

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 215 KB

english, 2013

30

Primary Therapy of Waldenström Macroglobulinemia With Nucleoside Analogue–Based Therapy

Souchet-Compain, Laetitia, Nguyen, Stéphanie, Choquet, Sylvain, Leblond, Véronique

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 201 KB

english, 2013

31

Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi

Olson, Daniel, Gulley, Margaret L., Tang, Weihua, Wokocha, Clifford, Mechanic, Oren, Hosseinipour, Mina, Gold, Stuart H., Nguluwe, Nelson, Mwansambo, Charles, Shores, Carol

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 392 KB

english, 2013

32

Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance and Smoldering Waldenström Macroglobulinemia

Kyle, Robert A., Therneau, Terry M., Dispenzieri, Angela, Kumar, Shaji, Benson, Joanne T., Larson, Dirk R., Melton, L. Joseph, Rajkumar, S. Vincent

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 258 KB

english, 2013

33

Comparative Response Assessment by Serum Immunoglobulin M M-Protein and Total Serum Immunoglobulin M After Treatment of Patients With Waldenström Macroglobulinemia

Tripsas, Christina K., Patterson, Christopher J., Uljon, Sacha N., Lindeman, Neal I., Turnbull, Barry, Treon, Steven P.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 178 KB

english, 2013

34

High Frequencies of Response After Limited Primary Therapy for Multiple Myeloma

Alexanian, Raymond, Delasalle, Kay, Wang, Michael

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 204 KB

english, 2013

35

Challenges With Serum Protein Electrophoresis in Assessing Progression and Clinical Response in Patients With Waldenström Macroglobulinemia

Uljon, Sacha N., Treon, Steven P., Tripsas, Christina K., Lindeman, Neal I.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 484 KB

english, 2013

36

Familial Predisposition to Monoclonal Gammopathies: Deviations in B-Cell Biology

Ögmundsdóttir, Helga M., Valgeirsdóttir, Sóley, Schiffhauer, Heather R., Óskarsdóttir, Lóa Björk, Steingrímsdóttir, Hlíf, Haraldsdóttir, Vilhelmína

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2013

Langue:

english

Fichier:

PDF, 508 KB

english, 2013

Volume 13; Issue 2

Clinical Lymphoma Myeloma and Leukemia

Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine

Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories

Survival in Monoclonal Gammopathy of Undetermined Significance and Waldenström Macroglobulinemia

Targeting the Toll-like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenström Macroglobulinemia

A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature

Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

microRNA Aberrations in Waldenström Macroglobulinemia

Role of Plasmapheresis in Waldenström's Macroglobulinemia

Desensitization to Lenalidomide in a Patient With Relapsed Multiple Myeloma

Table of Contents

Successful Use of Intrathecal Carboxypeptidase G2 for Intrathecal Methotrexate Overdose: A Case Study and Review of the Literature

Patients With Waldenström Macroglobulinemia Commonly Present With Iron Deficiency and Those With Severely Depressed Transferrin Saturation Levels Show Response to Parenteral Iron Administration

Therapy of Core Binding Factor Acute Myeloid Leukemia: Incremental Improvements Toward Better Long-Term Results

Intraclonal Heterogeneity in Concomitant Monoclonal Lymphocyte and Plasma Cell Populations: Combining Flow Cytometric Cell Sorting With Molecular Monoclonality Profiling

Genomic Abnormalities of Waldenström Macroglobulinemia and Related Low-Grade B-Cell Lymphomas

Bortezomib Administration With Severe Hyperbilirubinemia Caused by Hepatic Plasma Cell Infiltration: A Case Report

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Etiology of Waldenström Macroglobulinemia: Genetic Factors and Immune-related Conditions

Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenström Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance

Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia

Editorial Board/Masthead

Proceedings of the Seventh International Workshop on Waldenström Macroglobulinemia

Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib

Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells

Diagnostic Challenges of Amyloidosis in Waldenström Macroglobulinemia

Primary Therapy of Waldenström Macroglobulinemia With Nucleoside Analogue–Based Therapy

Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi

Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance and Smoldering Waldenström Macroglobulinemia

Comparative Response Assessment by Serum Immunoglobulin M M-Protein and Total Serum Immunoglobulin M After Treatment of Patients With Waldenström Macroglobulinemia

High Frequencies of Response After Limited Primary Therapy for Multiple Myeloma

Challenges With Serum Protein Electrophoresis in Assessing Progression and Clinical Response in Patients With Waldenström Macroglobulinemia

Familial Predisposition to Monoclonal Gammopathies: Deviations in B-Cell Biology